Key result
A systematic framework incorporating duration of symptoms and anticipated transport delays guides the selection of primary PCI versus thrombolytic therapy for STEMI patients.
Why the study?
What is the optimal reperfusion strategy (primary PCI vs thrombolytic therapy) for patients with ST-segment elevation myocardial infarction presenting to non-PCI capable hospitals?
Population
Patients with ST-segment elevation myocardial infarction (STEMI)
Design
Review
Authors
Loading...
May aid reperfusion decisions at non-PCI hospitals; leaves open prospective validation of the symptom- and delay-based algorithm.
What is the optimal reperfusion strategy (primary PCI vs thrombolytic therapy) for patients with ST-segment elevation myocardial infarction presenting to non-PCI capable hospitals?
This review provides a practical framework for clinicians to choose between primary PCI and thrombolytic therapy for STEMI patients based on ischemia time and transport delays.
Ting et al. (2006) conducted a review in ST-Segment Elevation Myocardial Infarction. Reperfusion strategies (primary PCI and thrombolytic therapy) was evaluated. A systematic framework incorporating duration of symptoms and anticipated transport delays guides the selection of primary PCI versus thrombolytic therapy for STEMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: